Fresenius Medical Care (FMS) Tops Q3 EPS by 35c

Fresenius Medical Care (NYSE: FMS) reported Q3 EPS of EUR0.73, EUR0.35 better than the analyst estimate of EUR0.38. Revenue for the quarter came in at EUR4.76 billion versus the consensus estimate of EUR5.4 billion.

For earnings history and earnings-related data on Fresenius Medical Care (FMS) click here.

You May Also Be Interested In

• Citi upgrades Bath & Body Works to Buy with $25 price target
• BNP Paribas Exane Downgrades Lanxess AG (LXS:GR) (LNXSF) to Underperform
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24